Article

Dementia drug demonstrates efficacy, safety in CPPS

Author(s):

Urology Times staff

Dr. Jordan Dimitrakov discusses the use of memantine in chronic pelvic pain syndrome with Urology Times.

Related Videos
3 experts are featured in this series.
Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment
3 experts are featured in this series.
Subgroup Analyses and Clinical Insights in Metastatic Hormone-Sensitive Prostate Cancer Treatment
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Investigators evaluate tamsulosin use in pediatric patients
Ruchika Talwar, MD, on how urologists can get involved in advocacy
Ruchika Talwar, MD, on how urologists can get involved in advocacy
Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
Chad Ellimoottil, MD, on how urologists should approach telehealth in changing policy environment
1 expert in this video
BPH: The Patient Journey
Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
How recombinant BCG could ease strain of supply issues
Katherine Chan, MD, on viral vs non-viral vectors in bladder cancer
Katherine Chan, MD, on viral vs non-viral vectors in bladder cancer
Dr Louise Kostos answers a question during a Zoom video interview
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
Related Content
CVAC2 shows safety, efficacy for stone clearance in real-world study
April 1st 2025

CVAC2 shows safety, efficacy for stone clearance in real-world study

Hannah Clarke
“The data presented at EAU25 add to the growing body of evidence supporting the CVAC System as the emerging standard of care in kidney stone removal,” says Brett Johnson, MD.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Breakthrough Study in Image-Guided Prostate Cancer Treatment
March 31st 2025

Breakthrough Study in Image-Guided Prostate Cancer Treatment

Yale School of Medicine
Published OPTIMUM Trial results compares high-resolution micro-ultrasound with MRI when considering prostate biopsy.
Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management
February 21st 2025

Episode 4 Podcast: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
18F-flotufolastat PET/CT shows high inter- and intrareader agreement rates
March 31st 2025

18F-flotufolastat PET/CT shows high inter- and intrareader agreement rates

Phillip Kuo, MD, PhD
"I think a take-home message there is that in the prostate/prostate bed, you have to take extra time and caution in reading that region," says Phillip H. Kuo, MD, PhD.
Subcutaneous nivolumab under review in EU for solid tumors
March 31st 2025

Subcutaneous nivolumab under review in EU for solid tumors

Hannah Clarke
The European Commission must issue a decision on the application on or by June 2, 2025.
© 2025 MJH Life Sciences

All rights reserved.